CVRx (CVRX) Common Equity (2020 - 2026)
CVRx's (CVRX) quarterly Common Equity came in at $29.1 million in Q1 2026, down 58.03% year-on-year from $69.4 million in Q1 2025, and down 25.98% quarter-over-quarter from $39.3 million in Q4 2025.
CVRx (CVRX) Common Equity (2020 - 2026) Analysis & Trends
CVRx's Common Equity history runs 7 years deep, the most recent figure standing at $29.1 million for Q1 2026.
- On a quarterly basis, Common Equity fell 58.03% year-over-year to $29.1 million in Q1 2026; TTM through Mar 2026 was $29.1 million, a 58.03% decrease from a year earlier, with the FY2025 full-year figure at $39.3 million, down 44.66% from the prior year.
- Common Equity eased to $29.1 million in Q1 2026 per CVRX's latest filing, from $39.3 million in the prior quarter.
- Across five years, Common Equity topped out at $136.8 million in Q1 2022 and bottomed at $29.1 million in Q1 2026.
- The 5-year median for Common Equity is $71.1 million (2024), against an average of $78.9 million.
- Across the five-year window, Common Equity soared 145.33% in 2022 and slumped 58.03% in 2026, its largest moves.
- Year by year, Common Equity stood at $109.2 million in 2022, then slumped by 30.44% to $75.9 million in 2023, then declined by 6.44% to $71.1 million in 2024, then slumped by 44.66% to $39.3 million in 2025, then retreated by 25.98% to $29.1 million in 2026.
- Per Business Quant, the three latest CVRX Common Equity figures stand at $29.1 million (Q1 2026), $39.3 million (Q4 2025), and $48.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | 29.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.11 Mn |
| Dec 31, 2025 | 39.32 Mn |
| Sep 30, 2025 | 48.05 Mn |
| Jun 30, 2025 | 57.93 Mn |
| Mar 31, 2025 | 69.36 Mn |
| Dec 31, 2024 | 71.06 Mn |
| Sep 30, 2024 | 65.18 Mn |
| Jun 30, 2024 | 55.25 Mn |
| Mar 31, 2024 | 66.26 Mn |
| Dec 31, 2023 | 75.95 Mn |
| Sep 30, 2023 | 82.83 Mn |
| Jun 30, 2023 | 89.96 Mn |
| Mar 31, 2023 | 99.64 Mn |
| Dec 31, 2022 | 109.18 Mn |
| Sep 30, 2022 | 118.24 Mn |
| Jun 30, 2022 | 127.15 Mn |
| Mar 31, 2022 | 136.80 Mn |
| Dec 31, 2021 | 145.96 Mn |
| Sep 30, 2021 | 155.76 Mn |
| Jun 30, 2021 | -318.93 Mn |